Literature DB >> 3749446

Cryptic miliary tuberculosis.

Y L Yu, W H Chow, M J Humphries, R W Wong, M Gabriel.   

Abstract

Fifteen patients with cryptic miliary tuberculosis seen over a six-year period in a large teaching hospital were reviewed. This form of tuberculosis tended to be difficult to diagnose and was most common in older people and those with underlying diseases such as malignancy or blood dyscrasias. Bacteriological investigation was of the little help in diagnosis while bone marrow and liver biopsies were more useful. The diagnosis was made during life in only seven (47 per cent) of the 15 cases, and the overall mortality was 80 per cent. Tuberculosis should be considered in all cases of pyrexia of unknown origin, and investigations performed to establish or exclude the diagnosis. A prompt and adequate therapeutic trial with antituberculous treatment even in the absence of definite evidence of tuberculosis can be life-saving.

Entities:  

Mesh:

Year:  1986        PMID: 3749446

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  5 in total

Review 1.  Tuberculosis: 6. Extrapulmonary disease.

Authors:  A Fanning
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  A case of cryptic miliary tuberculosis mimicking cholecystitis with sepsis.

Authors:  M Siemann; G Rabenhorst; A Bramann; C Renk
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

3.  Cryptic Disseminated Tuberculosis: a Secondary Analysis of Previous Hospital-Based Study.

Authors:  Fahmi Yousef Khan
Journal:  Tanaffos       Date:  2020-01

4.  Diagnosis and management of miliary tuberculosis: current state and future perspectives.

Authors:  Sayantan Ray; Arunansu Talukdar; Supratip Kundu; Dibbendhu Khanra; Nikhil Sonthalia
Journal:  Ther Clin Risk Manag       Date:  2013-01-08       Impact factor: 2.423

Review 5.  Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.

Authors:  Surendra K Sharma; Alladi Mohan
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.